Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Orencia | abatacept | Bristol Myers Squibb | N-125118 RX | 2005-12-23 | 5 products |
Brand Name | Status | Last Update |
---|---|---|
orencia | Biologic Licensing Application | 2024-12-13 |
Expiration | Code | ||
---|---|---|---|
abatacept, Orencia, Bristol-Myers Squibb Company | |||
2028-12-15 | Orphan excl. |
Code | Description |
---|---|
J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Arthritis | D001168 | EFO_0005856 | M05-M14 | 10 | 14 | 29 | 9 | 36 | 93 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 9 | 12 | 26 | 9 | 33 | 85 |
Kidney transplantation | D016030 | — | — | 2 | 8 | 3 | 3 | 3 | 18 |
Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | — | 1 | 1 | 1 | 3 | 6 |
Graft rejection | D006084 | — | — | — | 3 | — | 1 | — | 4 |
Delayed graft function | D051799 | — | — | 1 | 1 | — | 1 | — | 3 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | 1 | 1 | 1 | 3 |
Inflammation | D007249 | MP_0001845 | — | — | 1 | 1 | 1 | — | 3 |
Transplantation | D014180 | — | — | 1 | — | — | 1 | — | 2 |
Renal insufficiency | D051437 | — | N19 | — | — | 1 | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Syndrome | D013577 | — | — | 1 | 4 | 1 | — | — | 6 |
Juvenile arthritis | D001171 | EFO_1002007 | M08 | — | — | 3 | — | 2 | 5 |
Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | 1 | 5 | 1 | — | — | 5 |
Sjogren's syndrome | D012859 | EFO_0000699 | M35.0 | — | 3 | 2 | — | — | 5 |
Lupus nephritis | D008181 | EFO_0005761 | — | 1 | — | 1 | — | — | 2 |
Nephritis | D009393 | — | N05 | 1 | — | 1 | — | — | 2 |
Giant cell arteritis | D013700 | EFO_1001209 | M31.6 | — | — | 2 | — | — | 2 |
Polymyalgia rheumatica | D011111 | EFO_0008518 | M35.3 | — | — | 2 | — | — | 2 |
Myositis | D009220 | EFO_0000783 | G72.49 | — | 1 | 1 | — | — | 2 |
Vasculitis | D014657 | EFO_0006803 | M31 | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Graft vs host disease | D006086 | — | D89.81 | 1 | 2 | — | — | — | 3 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | 3 | — | — | — | 3 |
Interstitial lung diseases | D017563 | EFO_0004244 | J84.9 | — | 3 | — | — | — | 3 |
Psoriasis | D011565 | EFO_0000676 | L40 | 2 | 1 | — | — | — | 3 |
Organ transplantation | D016377 | — | — | — | 2 | — | — | — | 2 |
Covid-19 | D000086382 | — | U07.1 | 1 | 2 | — | — | — | 2 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | 1 | 2 | — | — | — | 2 |
Diffuse scleroderma | D045743 | EFO_0000404 | — | 1 | 2 | — | — | — | 2 |
Sclerosis | D012598 | — | — | — | 2 | — | — | — | 2 |
Heart transplantation | D016027 | EFO_0010673 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 3 | — | — | — | — | 3 |
Myasthenia gravis | D009157 | EFO_0004991 | G70.0 | 1 | — | — | — | — | 1 |
Muscle weakness | D018908 | — | — | 1 | — | — | — | — | 1 |
Vitiligo | D014820 | EFO_0004208 | L80 | 1 | — | — | — | — | 1 |
Bronchiolitis obliterans syndrome | D000092122 | — | D89.811 | 1 | — | — | — | — | 1 |
Behcet syndrome | D001528 | EFO_0003780 | M35.2 | 1 | — | — | — | — | 1 |
Relapsing polychondritis | D011081 | EFO_1001148 | M94.1 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
Islets of langerhans transplantation | D016381 | — | — | — | — | — | — | 1 | 1 |
Necrosis | D009336 | — | — | — | — | — | — | 1 | 1 |
Stem cell transplantation | D033581 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Abatacept |
INN | abatacept |
Description | 1-25-oncostatin M (human precursor) fusion protein with CTLA-4 (antigen) (human) fusion protein with immunoglobulin G1 (human heavy chain fragment), bimolecular (146-146')-disulfide |
Classification | Protein |
Drug class | receptor molecules or membrane ligands, natural, modified or modified: T-cell receptors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201823 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB01281 |
UNII ID | 7D0YB67S97 (ChemIDplus, GSRS) |